Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Notice to Long-Term Investors of Soleno Therapeutics, Inc. (SLNO): Grabar Law Office Investigates Claims on Your Behalf
Grabar Law Office is investigating Soleno Therapeutics, Inc. (SLNO) on behalf of long-term investors, alleging the company made materially false and misleading statements regarding the safety and commercial viability of its drug DCCR (VYKAT XR). The investigation highlights claims of undisclosed safety concerns in clinical trials, including excess fluid retention and a patient death, which led to a significant drop in stock price from over $90 to below $45 per share. Shareholders who purchased prior to March 26, 2025, are encouraged to contact the firm, and those who bought between March 26, 2025, and November 4, 2025, may be eligible for a securities fraud class action.